Chemical inhibitors of AFG3-like AAA ATPase 1 can affect the protein's function through various mechanisms, primarily by altering the mitochondrial environment or by directly inhibiting molecular pathways that are crucial for its activity. Oligomycin A, for instance, directly inhibits mitochondrial ATP synthase, leading to a decrease in ATP production. Since AFG3-like AAA ATPase 1 requires ATP to function, a reduction in ATP levels can inhibit the protein's ATPase activity. Similarly, Concanamycin A affects the protein indirectly by inhibiting V-ATPases, which are essential for maintaining the acidification of intracellular organelles, including mitochondria. The altered pH can affect the functionality of AFG3-like AAA ATPase 1. Another compound, CCCP, disrupts the mitochondrial membrane potential by uncoupling oxidative phosphorylation, which is fundamental for the maintenance of the electrochemical gradient required by mitochondrial proteins, including AFG3-like AAA ATPase 1.
Further affecting the protein's activity, proteasome inhibitors like Epoxomicin, Bortezomib, and MG-132 can lead to the accumulation of misfolded or damaged proteins within the cell, overwhelming the protein degradation pathway that involves AFG3-like AAA ATPase 1. This can indirectly inhibit the protein by preventing it from adequately performing its role in mitochondrial protein quality control. Similarly, mdivi-1, by inhibiting mitochondrial division, can disrupt the regular balance of mitochondrial dynamics, thereby potentially affecting the functional activity of AFG3-like AAA ATPase 1 in the process of mitochondrial maintenance. Other compounds like Alisertib and Parthenolide act more indirectly; Alisertib by inhibiting aurora kinase A which is involved in mitochondrial dynamics, and Parthenolide by inhibiting the NF-kB pathway, which can influence mitochondrial function and maintenance. Lastly, Chloroquine disrupts lysosome acidification and the autophagy process, which is linked to the mitochondrial quality control network that AFG3-like AAA ATPase 1 is a part of, thus affecting the protein's role in mitochondrial maintenance.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Oligomycin A | 579-13-5 | sc-201551 sc-201551A sc-201551B sc-201551C sc-201551D | 5 mg 25 mg 100 mg 500 mg 1 g | $179.00 $612.00 $1203.00 $5202.00 $9364.00 | 26 | |
Inhibits mitochondrial ATP synthase, potentially reducing ATP levels required for AFG3-like AAA ATPase 1 activity. | ||||||
MLN8237 | 1028486-01-2 | sc-394162 | 5 mg | $220.00 | ||
Targets aurora kinase A, which may affect mitochondrial dynamics and indirectly inhibit AFG3-like AAA ATPase 1. | ||||||
Parthenolide | 20554-84-1 | sc-3523 sc-3523A | 50 mg 250 mg | $81.00 $306.00 | 32 | |
Inhibits the NF-kB pathway, potentially affecting mitochondrial function and AFG3-like AAA ATPase 1 indirectly. | ||||||
Concanamycin A | 80890-47-7 | sc-202111 sc-202111A sc-202111B sc-202111C | 50 µg 200 µg 1 mg 5 mg | $66.00 $167.00 $673.00 $2601.00 | 109 | |
Inhibits V-ATPases, possibly affecting organelle pH and AFG3-like AAA ATPase 1 function. | ||||||
Epoxomicin | 134381-21-8 | sc-201298C sc-201298 sc-201298A sc-201298B | 50 µg 100 µg 250 µg 500 µg | $137.00 $219.00 $449.00 $506.00 | 19 | |
Proteasome inhibitor, which may interfere with the protein degradation pathway involving AFG3-like AAA ATPase 1. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
Proteasome inhibitor, potentially leading to protein accumulation and inhibition of AFG3-like AAA ATPase 1. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
Reversible proteasome inhibitor, potentially overloading mitochondrial protein quality control including AFG3-like AAA ATPase 1. | ||||||
Mdivi-1 | 338967-87-6 | sc-215291 sc-215291B sc-215291A sc-215291C | 5 mg 10 mg 25 mg 50 mg | $67.00 $126.00 $251.00 $465.00 | 13 | |
Inhibits mitochondrial division, which may indirectly affect AFG3-like AAA ATPase 1's role in mitochondrial dynamics. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
Disrupts lysosome acidification and autophagy, possibly affecting AFG3-like AAA ATPase 1's maintenance role. | ||||||
Carbonyl Cyanide m-Chlorophenylhydrazone | 555-60-2 | sc-202984A sc-202984 sc-202984B | 100 mg 250 mg 500 mg | $77.00 $153.00 $240.00 | 8 | |
Uncouples oxidative phosphorylation, potentially inhibiting mitochondrial proteins including AFG3-like AAA ATPase 1. | ||||||